Ask AI
ProCE Banner Activity

What IAS 2025 Means for HIV Care in the Asia-Pacific Region

Clinical Thought

Gain insight on key updates from IAS 2025 with major implications for the Asia-Pacific region, including updates to the 2025 World Health Organization HIV Treatment guidelines, advances in long-acting ART, and new evidence supporting same-day ART initiation for people with HIV and presumptive TB. 

Released: August 20, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

 
ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

N. Kumarasamy, MBBS, FRCP, PhD, has no relevant financial relationships to disclose.